C12ORF11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.828400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.569000E-01
Normal-vs-Stage2
9.196600E-01
Normal-vs-Stage3
5.375000E-01
Normal-vs-Stage4
5.238400E-01
Stage1-vs-Stage2
7.434200E-01
Stage1-vs-Stage3
6.484200E-01
Stage1-vs-Stage4
2.693200E-01
Stage2-vs-Stage3
4.335400E-01
Stage2-vs-Stage4
3.854400E-01
Stage3-vs-Stage4
2.861400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.278400E-01
Normal-vs-AfricanAmerican
4.102800E-01
Normal-vs-Asian
3.643600E-01
Caucasian-vs-AfricanAmerican
4.292200E-01
Caucasian-vs-Asian
2.756800E-01
AfricanAmerican-vs-Asian
9.805400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.261400E-01
Normal-vs-Female
8.369000E-01
Male-vs-Female
6.552800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.354200E-02
Normal-vs-Age(41-60Yrs)
8.265400E-01
Normal-vs-Age(61-80Yrs)
6.702000E-01
Normal-vs-Age(81-100Yrs)
8.062600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.650400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.840800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.631600E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.482200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.912600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.495160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.896000E-01
Normal-vs-Daily Drinker
8.096200E-01
Normal-vs-Weekly Drinker
6.810800E-01
Normal-vs-Occasional Drinker
7.315800E-01
Normal-vs-Social Drinker
9.441400E-01
Non Drinker-vs-Daily Drinker
9.489600E-01
Non Drinker-vs-Weekly Drinker
9.163200E-01
Non Drinker-vs-Occasional Drinker
2.778000E-01
Non Drinker-vs-Social Drinker
6.498600E-01
Daily Drinker-vs-Weekly Drinker
8.715600E-01
Daily Drinker-vs-Occasional Drinker
3.142400E-01
Daily Drinker-vs-Social Drinker
6.977000E-01
Weekly Drinker-vs-Occasional Drinker
2.003600E-01
Weekly Drinker-vs-Social Drinker
5.386800E-01
Occasional Drinker-vs-Social Drinker
4.813600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.269800E-01
Normal-vs-Grade 2
2.392200E-01
Normal-vs-Grade 3
2.570600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.386020E-01
Grade 1-vs-Grade 3
3.699200E-03
Grade 1-vs-Grade 4
4.269800E-01
Grade 2-vs-Grade 3
3.205700E-02
Grade 2-vs-Grade 4
2.392200E-01
Grade 3-vs-Grade 4
2.570600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.588400E-01
Normal-vs-NonDiabetic
8.611000E-01
Diabetic-vs-NonDiabetic
5.548400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.522200E-01
Normal-vs-NoPancreatitis
8.573200E-01
Pancreatitis-vs-NoPancreatitis
5.413400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.220200E-01
Normal-vs-N1
9.924000E-01
N0-vs-N1
1.261170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.690600E-01
Normal-vs-TP53-NonMutant
8.484200E-01
TP53-Mutant-vs-TP53-NonMutant
7.856700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
